NRCME Diabetes Mellitus Standards 5 — Questions and Answers
Question 1: A commercial driver with diabetes is found to have microalbuminuria. This is most relevant to the examiner because it indicates:
- Increased risk of seizure
- Early diabetic kidney disease and elevated cardiovascular risk (Correct answer)
- Peripheral nerve damage only
- Retinal hemorrhage risk within 30 days
Correct answer: Early diabetic kidney disease and elevated cardiovascular risk
Microalbuminuria signals early nephropathy and is a marker of systemic vascular disease that elevates overall cardiovascular risk.
Question 2: When a driver with diabetes reports using a continuous glucose monitor (CGM), the examiner should understand that:
- CGM use automatically qualifies the driver for exemption
- CGM is a monitoring tool and does not change FMCSA qualification requirements (Correct answer)
- CGM replaces the need for finger-stick checks under exemption protocols
- CGM data must be submitted to FMCSA monthly
Correct answer: CGM is a monitoring tool and does not change FMCSA qualification requirements
CGM is a useful monitoring device but does not alter the legal qualification framework; drivers must still meet all FMCSA standards.
Question 3: A driver with diabetes reports blurred vision that resolves after glucose correction. This symptom is medically significant because it suggests:
- Permanent retinal damage requiring immediate ophthalmology referral
- Episodic hypoglycemia or hyperglycemia causing transient visual changes that impair driving (Correct answer)
- Normal accommodation variation in diabetic patients
- Cataracts unrelated to glucose levels
Correct answer: Episodic hypoglycemia or hyperglycemia causing transient visual changes that impair driving
Transient vision changes tied to glucose fluctuation indicate glycemic instability that can impair driving safely.
Question 4: What is the primary reason FMCSA originally prohibited insulin-treated drivers from interstate commerce?
- Insulin causes drowsiness as a side effect
- Risk of hypoglycemia causing sudden incapacitation while driving (Correct answer)
- Insulin injections are incompatible with long-haul schedules
- Insulin users have higher rates of cardiovascular disease
Correct answer: Risk of hypoglycemia causing sudden incapacitation while driving
The original prohibition was based on the risk that hypoglycemia could cause sudden loss of cognitive function or consciousness at the wheel.
Question 5: A driver with Type 2 diabetes switches from metformin to a GLP-1 receptor agonist. From an FMCSA standpoint, the primary consideration is:
- GLP-1 agents require immediate disqualification
- GLP-1 agents have low hypoglycemia risk and generally do not change certification status (Correct answer)
- GLP-1 agents require the same exemption process as insulin
- The driver must re-apply for certification from scratch
Correct answer: GLP-1 agents have low hypoglycemia risk and generally do not change certification status
GLP-1 receptor agonists have a very low hypoglycemia risk when used without insulin, so they typically do not trigger additional FMCSA restrictions.
Question 6: Which scenario would most likely result in the examiner issuing a shorter than standard certification period for a diabetic CMV driver?
- HbA1c of 6.8% with no complications
- Recent medication change requiring stability confirmation (Correct answer)
- Driver aged under 45 with Type 2 diabetes
- Driver using metformin for 10+ years without issues
Correct answer: Recent medication change requiring stability confirmation
A recent medication change warrants a shorter certificate to verify glycemic stability and absence of adverse effects before full-period certification.
Question 7: A driver with diabetes presents with a foot ulcer that is healing but not infected. The examiner's main concern regarding CMV safety is:
- Risk of sepsis spreading to the CNS
- Whether peripheral neuropathy or vascular insufficiency compromising foot function affects pedal control (Correct answer)
- Cosmetic appearance of the wound
- Risk of the ulcer contaminating the cab environment
Correct answer: Whether peripheral neuropathy or vascular insufficiency compromising foot function affects pedal control
Foot ulcers often indicate peripheral neuropathy or vascular disease that may impair the driver's ability to reliably use foot pedals.
NRCME Diabetes Mellitus Standards 5
A commercial driver with diabetes is found to have microalbuminuria.
This is most relevant to the examiner because it indicates: